Aarti Surfactants Board Approves FY26 Dividend, Reappoints Auditors and Committee Member
Aarti Surfactants Limited approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board recommended a dividend of ₹1 per share for FY26. PHS & Associates and Raman S. Shah & Co. were reappointed as Cost and Internal Auditors, respectively. Mr. Parimal H. Desai joined the Finance and Investment Committee.
The dividend recommendation and approval of financial results are material events for shareholders. Reappointment of auditors and committee changes are standard corporate governance actions with moderate impact.
The company reported financial results and recommended a dividend, indicating positive financial performance and shareholder returns. Reappointment of auditors and committee changes are routine corporate actions.
Aarti Surfactants Limited's Board of Directors, in a meeting held on Saturday, May 09, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board also recommended a dividend of ₹1 per equity share (10%) for the Financial Year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting.
Further, the company re-appointed PHS & Associates as the Cost Auditor and Raman S. Shah & Co. as the Internal Auditor for FY 2026-2027. The Finance and Investment Committee of the Board was re-constituted with the inclusion of Mr. Parimal H. Desai as a Member, effective immediately.
The financial results for the quarter ended March 31, 2026, showed standalone revenue from operations of ₹25,627.66 Lakhs and a net profit after tax of ₹426.31 Lakhs. Consolidated revenue from operations stood at ₹25,627.66 Lakhs with a net profit after tax of ₹418.55 Lakhs.
The Board meeting commenced at 11:40 a.m. and concluded at 02:00 p.m. The financial results and other information are available on the company's website.
What to do with a filing like this
Aarti Surfactants Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarti Surfactants Limited. Read the original for the full detail.